Medtronic Strengthens Hand in Ablation Market with CryoCath Acquisition

Competitors in the cardiac rhythm management space are drawing new battlelines in the area of atrial ablation. Medtronic's acquisition of CryoCath pits it against historical rivals St. Jude and Boston Scientific.

More from Archive

More from In Vivo